Compare IDEXX Laboratories, Inc. (IDXX) vs Zillow Group Inc Class A (ZG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
IDEXX Laboratories, Inc. vs Zillow Group Inc Class A — how do they compare? IDEXX Laboratories, Inc. trades at $551 (market cap $44.48B), while Zillow Group Inc Class A trades at $31.64 (market cap $7.54B). The key difference: IDEXX Laboratories, Inc. is far larger — about 5.9× Zillow Group Inc Class A's market cap. Which is the better fit depends on your goals.
| IDXX | ZG | |
|---|---|---|
Market Cap | $44.48B | $7.54B |
Sector | Health | Media |
52-Week High | $766.68 | $86.76 |
52-Week Low | $520.87 | $29.14 |
Enterprise Value | $45.38B | $7.19B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
IDXX trades at $563.79, down 0.64% today but maintains strong fundamental momentum with consistent earnings beats and robust profitability. The stock shows bullish technical signals with support at $563 and resistance at $572, while valuation metrics remain elevated. Recent Q1 2026 results exceeded expectations with EPS of $3.47 versus $3.41 estimates, supporting the company's leadership in veterinary diagnostics.
Outlook remains positive given strong analyst support (59% buy ratings) and innovation pipeline, though premium valuations and competitive pressures present risks. Revenue growth trajectory and expanding margins provide fundamental support for continued upside potential in the pet healthcare sector.
Zillow Group (ZG) trades at $32.84, down 2.58% on the day, amid a bearish technical signal and ongoing securities class action lawsuits. The company reported revenue of $2.58B in 2025 with a net income of $23M, marking a return to profitability after losses in prior years. Analyst consensus is a Buy with a $57.80 price target, but recent news highlights legal risks from alleged anticompetitive practices.
The outlook is mixed: strong fundamentals with improving margins and revenue growth support upside potential, but legal overhangs and bearish technicals pose near-term risks. Investors should weigh the high P/E ratio of 134.8 against earnings beats and analyst optimism for long-term recovery.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About IDEXX Laboratories, Inc.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →About Zillow Group Inc Class A
Zillow Group is an Internet-based real estate company that has historically focused on deriving ad revenue from third-party brokers on online marketplaces such as Zillow.com, Trulia, and HotPads. More recently it has shifted its focus to iBuying via the Zillow Offers platform.
Read more on ZG →
